Introduction
One of the major technical hurdles for clinical application of embryonic stem (ES) cells or induced pluripotent stem (iPS) cells is formation of teratomas by undifferentiated cells after transplantation. In addition, iPS cells have their own safety concerns such as an increased chance of tumorigenicity caused by chromosomal instability or alteration during the reprogramming process (1) . Since the first report of mouse iPS cell generation by retroviral vectors (2) , several non-integrating vector systems have been examined in pursuit of "safer" iPS cell generation methods. These approaches include adenoviruses (3), Sendai viruses (SeV) (4, 5) , Cre-excisable viruses (6) , the piggyBac transposition system (7, 8) conventional plasmids (9) , the oriP/EBNA1-episomal vector (10) , direct protein delivery methods (11, 12) or small molecule delivery methods (13, 14) . A number of cell sources for generating human iPS cells have been reported, including dermal fibroblasts (15) , keratinocytes (16) , peripheral blood cells (17) , adipose tissue (18) , and cord blood (CB) cells (19) . The three germ layer differentiation potential of these established iPS cells has been demonstrated. However, it is not clear which cell source is best for generating "standard" iPS cells, as differentiation preferences of established iPS cells reflect the epigenetic status of the original cells (called "epigenetic memory") (20) . Recently, several groups reported new insights into two distinct stages of pluripotency in ES cells. These stem cell stages consist of the inner cell mass (ICM) of blastocyst type (ICM type-cells or naïve cells), and epiblast type stem cells (EpiSCs or prime cells) (21) . Mouse 129 or C57/BL6 mouse ES cells are the ICM type: "true" pluripotent stem cells representing preimplantation blastocysts that contribute to chimerism and demonstrate germ line transmission when placed back into blastocysts. They can also be grown in single cell suspension. In contrast, the "EpiSCs" or "prime" ES cells represent post-implantation stage epiblasts. They retain the potential of three germ line differentiation in vitro, but are incapable of contributing to chimerism and cannot survive after single cell cloning. Human ES cells or iPS cells seem to correspond to the EpiSCs with respect to colony morphology www.intechopen.com Embryonic Stem Cells -Differentiation and Pluripotent Alternatives 400 and gene expression prolife (22, 23) , but can be converted to the naïve stem cell stage by cultivation (24) or constitutive activation of KLF2/KLF4 genes (25) . In this report, we demonstrate an easier and safer reprogramming method for the direct establishment of ICM-type human iPS cells from fresh or frozen CB cells using temperature-sensitive SeV vectors, which facilitates confirmation of removal of the SeV construct at a single cell level.
Experimental procedures, materials, and methods
All experimental protocols were reviewed and approved by the ethical committee of the Riken Center for Developmental Biology (CDB), the Foundation for Biomedical Research and Innovation (FBRI), Asagiri Hospital, and the animal experiment committee of FBRI. Fresh CB was supplied by Asagiri Hospital. CD34 + cells were purified from mononuclear cells (isolated from fresh CB with Lymphoprep TM (Cosmo Bio Co., Tokyo, Japan)) using a human CD34 Micro Bead kit and Auto Macs columns (Miltenyi Biotec) in accordance with the manufacturer's instruction. We also used frozen CD34 + CB cells obtained from Riken RBC (Tsukuba, Japan). CD34 + cells were cultured in hematopoietic culture medium (HC media) [serum free X-VIVO 10 (Lonza, Basel Switzerland) containing 50 ng/mL IL-6 (Peprotech, London UK), 50 ng/mL sIL-6R (Peprotech), 50 ng/mL SCF (Peprotech), 10 ng/mL TPO (Peprotech), 20 ng/mL Flt3-ligand (R&D system, MN)] (4) for one day prior to viral infection. SNL76/7 feeder cells (European Collection of Cell Culture, Salisbury, UK) were treated with 100 L of mitomycin C solution (1 mg/mL) (Nacalai Tesque, Kyoto, Japan) in 10 cm dishes for three hours to generate mitomycin C treated-SNL 76/7 feeder cells (MMC-SNL). They were seeded on 24-well plates (Becton Dickinson, Tokyo, Japan), or in six-well plates, or in 60 mm dishes in naïve human ES cell culture medium. Fifty mL of naïve human ES cell medium was prepared by mixing 24 mL DMEM/F12 (Invitrogen; 11320), 24 mL Neurobasal (Invitrogen; 21103), 0.5 mL of x100 nonessential amino acids (Invitrogen), 1 mL B27 supplement (Invitrogen; 17504044), and 0.5 mL N2 supplement (Invitrogen; 17502048). The medium also contained 0.5 mg/mL of BSA Fraction V (Sigma), penicillin-streptomycin (final x 1, Invitrogen), 1 mM glutamine (Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen), 1.0 M PD0325901 (Stemgent), 3.0 M CHIR99021 (Stemgent), 10 M forskolin (Sigma) and 20 ng/mL of recombinant human LIF (Millipore; LIF1005). Prime human iPS cells were cultured with prime human ES cell medium [DMEM/F-12 (SIGMA) containing 20% KSR (Invitrogen), 2 mM L-glutamine (Invitrogen), 1% NEAA (Invitrogen), 0.1 mM 2-ME (Invitrogen), and 4 ng/mL bFGF (Peprotech)]. The medium was changed every day. Passage of human ES cell-like cells was previously described (26) . The split ratio was routinely 1:3 or 1:4. 
Viral infection and generation of ICM-type iPS cells

Optimized culture conditions for naïve iPS cells
1X10 4 SeV-infected CD34 + CB cells were transferred onto various numbers of pre-seeded MMC-SNL cells in 60 mm dishes (from 1.0 x 10 5 to 2.0 x 10 6 ). Cells were cultured for 14 days in naïve human ES cell medium either under hypoxic or normoxic conditions. The emergent colonies were fixed and stained for ALP activities. The number of colonies stained positively for ALP activities was scored. The naïve ES cell-like colonies were picked up 14 to 19 days after seeding on SNL in naïve ES cell medium under 5% O 2 culture conditions. These cells were subjected to heat treatment at 38 o C for three days at passage two in the naive state. After heat treatment, prime ES cell-like colonies were passaged (passage three) and checked for residual SeV constructs by RT-PCR and immunostaining with anti-SeV antibody. Then, the virus-free cell clumps from passage three were cultured in prime human ES cell medium under 20% O 2 culture conditions. Viral-Free (VF) iPS cell colonies were passaged two or three times and then tested for further appraisal of differentiation potential of the reprogrammed cell clones. We tried to induce pluripotency in adherent cells derived from CD34 + cells in Table 1 Clone # RT-PCT (undifferentiation) Table 1 . Efficiency of induction of iPSC clones from cord blood cells with SeV vectors.
Alkaline phosphatase and immunohistological staining
Naive ES cell like-and prime ES cell like-colonies were stained with leukocyte alkaline phosphatase kit (VECTOR, Burlingame, CA) in accordance with the manufacturer's instructions. Cells were fixed with 4% paraformaldehyde followed by immunostaining with a series of antibodies. Nuclei were stained with DAPI (1:1000, SIGMA). Photomicrographs were taken with a fluorescent microscope (Olympus BX51, IX71, Tokyo) and a visible light microscope (Olympus CKX31). Expression of CD34 and CD45 in mononuclear cells (MNC) from CB was determined by flow cytometry (middle). CD34 + CD45 low+ cells (0.2%) and CD34 -CD45 + cells were fractionated by cell sorting and both were infected with SeV carrying four factors and GFP. Phase contrast microscopic and fluorescence photographs of CD34 + cells (right) and CD34 -mononuclear cells (left) the day after infection are shown in lower panels. We found that the GFP + population was selectively found in the CD34 + fraction the day after SeV infection ( Fig. 2) . This fraction corresponds to hematopoietic stem cells or progenitors, as reported elsewhere (27).
Determination of SeV construct in naïve ES cell-like cells
The remaining SeV constructs in naïve ES cell-like colonies were determined by RT-PCR and immunostaining. Using four temperature-sensitive Sendai viral constructs (SeV TS7) integrating Yamanaka's transcription factor quartet (c-MYC, KLF4, OCT3/4 and SOX2), we were able to generate ES cell-like colonies from CD34 + CD45 low+ CB cells. The protocol for generating iPS cells from CB cells with temperature-sensitive SeV vector is shown in Fig. 1 . Naïve ES cell-like colonies were generated by culturing cells in naïve human ES cell medium under hypoxic conditions (5% O 2 ). Merged dome-like colonies were picked up three weeks after SeV infection and subjected to heat treatment at 38 o C to reduce the amount of residual SeV constructs. Remaining SeV constructs were detected by RT-PCR and immunostaining with anti-SeV antibody. Then, the cell clumps of "naïve" virus-free cell clones were transferred to conventional prime human ES cell medium and cultured under normoxic conditions (20% O 2 ) to convert cells to "prime" virus-free ES cell-like cells. We cannot maintain the naïve state for more than five passages due to the instability of pluripotency in naïve culture conditions and the tendency for spontaneous differentiation. In contrast, pluripotency in the prime state (like conventional human ES cells) was stable and we could maintain prime ES or iPS cells for more than 50 passages. Therefore, further appraisal of the differentiation potential of the reprogrammed cells was done in the prime state (Fig. 4A,B) . Naïve ES cell-like clones from a single cell suspension were examined. Like mouse ES cells, emergent dome-like colonies (P = 1) started to express SSEA-1 in the naïve stage (Fig. 3C , lower left ), but its expression ceased after shifting to the prime state (Fig. 3C, lower right) . Expression of pluripotency-related molecules in the prime state was examined by immunostaining with a set of antibodies ( Table 2 ). The presence of SeV constructs in the naïve reprogrammed cells was examined by RT-PCR at the single cell level (Fig. 3D) . Heattreated naïve clones that were free of SeV constructs under hypoxic conditions (5% O 2 ) were transferred to prime culture with a normoxic atmosphere (20% O 2 ). These virus-free ES cell like-clones were expanded in conventional prime human ES cell culture for further appraisal of the differentiation potential. , and #37 were subject to heat treatment (passage 2: P = 2) and subcloned. Subclones were named #24VF, #35VF, or #37VF (passage 3: P = 3). iPS cells generated from CB by retrovirus (ReV) and parent CD34 + CB cell were used as negative controls. % SeV + in colony is the area positively stained with anti-SeV antibody divided by the total area of the colony calculated by two value recognition software (Adobe Photoshop). There was no difference in the frequency of emerging dome-shaped ES cell-like colonies in the naïve state from freshly isolated CD34 + cells and from frozen CD34 + cells. 
Characterization of virus-free ES cell-like clones 2.2.1 Reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA was purified with RNeasy Mini kit (QIAGEN), according to the manufacturer's instructions. One g of total RNA was used for reverse transcription reactions with PrimeScript RT reagent kit (TAKARA, Japan). PCR was performed with EXTaq (TAKARA, Japan). Total RNA from cell clones was extracted with the RNeasy minikit (QIAGEN). q-RT-PCR was performed with an ABI PRISM 7000 (Life Technologies Japan) using SYBR Premix EX Taq TM (TAKARA, RR041A) in accordance with the manufacturer's instructions. Primers are listed in Table 3 . TTG GCA GGT TTT TCT AGA CGG  hBRACHYURY-F1292  GCC CTC TCC CTC CCC TCC ACG CAC AG  mesoderm  274  hBRACHYURY-R1540  CGG CGC CGT TGC TCA CAG ACC ACA GG   hPAX6-F1206  ACC CAT TAT CCA GAT GTG TTT GCC CGA G ectoderm  317  hPAX6-R1497  ATG GTG AAG CTG GGC ATA GGC GGC AG  hSOX17-F423  CGC TTT CAT GGT GTG GGC TAA GGA CG  endoderm  608  hSOX17-R583  TAG TTG GGG TGG TCC TGC ATG TGC TG  SeV vector F15204 GGATCACTAGGTGATATCGAGC  SeV vectors  193  SeV vector R15397e CATATGGACAAGTCCAAGACTTC   Table 3 . List of primers used to detect pluripotency-associated genes in reprogrammed cells.
Gene Chip analysis and karyotyping
instructions. Karyotyping of established iPS cells was reported by Nihon Gene Research Laboratories, Inc. (Sendai, Japan). The expression of pluripotency-related molecules in the prime stage such as SSEA-4, SSEA-3, TRA-1-60, TRA-1-81, Oct3/4 and Nanog were detected by immunostaining (Fig. 4A) . Endogenous expression of pluripotency-related genes was determined by RT-PCR (Fig. 4B) . Total gene expression profiles of the established iPS clone SeV iPS #37VF are compared with human ES cell line KhES-3 or CD34 + cord blood cells (Fig. 4C) . Karyotype of the established iPS cell clone SeV iPS #37VF is presented (Fig. 4D ).
Differentiation assays of virus-free iPS cells in vitro and in vivo 2.3.1 In vitro differentiation assay
Established human ES cell-like clones were harvested using collagenase IV. Cells were transferred to six-well ultra-low attachment plates (Corning) and cultured in human prime ES cell medium without bFGF to form embryoid bodies (EB). The medium was changed every other day. The resulting EBs were transferred to gelatin-coated plates after eight days and cultured in the same fresh medium for another eight days. Three cell lines were tested for differentiation potential on gelatin coated dishes after EB formation (Fig. 5a ). All of these (Fig. 5b) and immunocytochemistry ( Fig. 5c-g ). Upon differentiation, the presence of gene expression characteristic of all three germ layers was determined by RT-PCR (Fig. 5h ).
In vivo differentiation assay
One million iPS cells were injected beneath the testicular capsule of SCID mice (SLC Japan) for teratoma formation. Tumor formation was observed 60 -80 days after cell transplantation. Tumor tissues were fixed with 4% formalin followed by hematoxylin and eosin staining. Two lines were tested for teratoma formation and both cell lines formed teratomas with a cystic structure (Fig. 5i) . HE staining of teratoma tissues (Fig. 5j -5n ) showed differentiated tissues corresponding to all three germ layers.
Conclusions
Reprogramming of somatic cells with SeV vector without DNA integration is advantageous, as it reduces the chance for tumorigenicity caused by random genomic integration. Advantages of using SeV vector over other non-integrating reprogramming methods such as using adenovirus, episomal plasmid vectors, conventional plasmid vectors, or small molecule delivery systems include superior reprogramming capability with potent protein expression potential (13) . The remaining concern in using SeV vector is how we can confirm the removal of potent SeV vectors from reprogrammed cells. In this report, we used the temperature-sensitive SeV vector TS7 to reduce the number of SeV-infected cells. In addition, we made use of a single cell cloning technique in the naïve state to confirm the absence of SeV vector constructs in the reprogrammed cells at a single cell level. Therefore, this cloning technique provides an ultimate solution for RNA virus vector-based reprogramming methodology. The benefits of reprogramming somatic cells in the naïve state are not limited to a single cell cloning technology. It may provide answers to interesting questions like whether "standard" human iPS cells, having the correct epigenetic memory, can be generated by reprogramming somatic cells in the naïve state. Accumulation of epigenetic information before and after transferring to the naïve state would provide an answer to this question. Several reports showed that iPS cells can be preferentially generated from the CD34 + fraction of CB cells and peripheral blood cells with retroviral vectors (19, 26) . In our experiment, we also showed that the SeV TS7-GFP vector selectively infects freshly isolated 
